Tagged Articles

GranuFlo 77 articles

Dialysis giant Fresenius urges judge to toss GranuFlo, NaturaLyte lawsuits

Fresenius USA, the world’s largest provider of dialysis services and products, pressed a federal judge to throw out hundreds of Massachusetts and Mississippi lawsuits consolidated in a multidistrict litigation (MDL) alleging the company’s dialysis products GranuFlo and NaturaLyte caused patients’ hearts to stop beating. Fresenius’ motion included 169 cases in Massachusetts and 61 in Mississippi. The company contends that the Massachusetts cases were filed more than three years after May 25, 2012 – the date the Food and Drug Administration (FDA) issued a safety warning regarding the products. Fresenius claims the Mississippi cases involved injuries that occurred after May 25, ... Read More

Study focuses on reducing sudden cardiac death in dialysis patients

Patients with end-stage kidney disease are at high risk of sudden cardiac death when they begin dialysis treatment. A team of researchers with the University of Rochester Medical Center are conducting the largest clinical study of its kind focused on reducing sudden death in dialysis patients. Sudden cardiac death is the single largest cause of death in dialysis patients, occurring in about a quarter of dialysis patients. It is defined by a sudden and unexpected death caused by loss of heart function. Dialysis is a treatment that filters the blood to rid the body of harmful waste and extra salt ... Read More

Fresenius fights wrongful death lawsuits involving GranuFlo, NaturaLyte

Fresenius USA Inc., is trying to shake one of hundreds of lawsuits consolidated in a multidistrict litigation alleging its dialysis concentrates GranuFlo and NaturaLyte can cause patients to suffer fatal cardiopulmonary arrest. The dialysis products and services giant claims a woman’s death occurred after the company warned patients of heart risks with the products. Celia D. Ware filed a failure-to-warn claim in Mississippi after her sister died in January 2014 after undergoing dialysis treatment in which the dialysis concentrates were used. Ware’s lawsuit claims that a dosing error with GranuFlo and NaturaLyte caused too much bicarbonate to build up in ... Read More

Fresenius slapped with wrongful death lawsuit

A man is suing Fresenius Medical Care and others, claiming negligence on behalf of the dialysis company and members of Huntington Internal Medicine Group in Huntington, W. Va., which he claims caused injuries and the premature death of his father. John. E. Bourdelais was undergoing dialysis treatment under the care of the defendants on July 13, 2013, when he suffered life-threatening injuries including hemorrhagic shock, cardiopulmonary arrest, bilateral pleural effusions, cardiac arrhythmias, hypovolemic arrest, traumatic hemothorax and multiple fractured ribs secondary to resuscitation. This, the lawsuit claims, shortened his life by two years. The lawsuit was filed by John M. ... Read More

Dialysis products GranuFlo, NaturaLyte linked to sudden cardiac arrest

Attorneys with Beasley Allen Law Firm are investigating cases of cardiac events including sudden cardiac arrest in patients who underwent dialysis treatment in which GranuFlo or NaturaLyte concentrates were used. GranuFlo and NaturaLyte are used to balance electrolytes in patients undergoing dialysis treatment. They are made by Fresenius Medical Care, and are used in both Fresenius-owned and non-Fresenius-owned dialysis clinics. The products metabolize into a substance called bicarbonate within the body. Elevated levels of bicarbonate can cause heart problems including heart attacks, sudden cardiac arrest, and death. Fresenius became aware that the dosing instructions printed on labels of GranuFlo and ... Read More

Fresenius faces lawsuits alleging injury, death from defective dialysis products

Lawsuits were filed against Fresenius Medical Care in a Kentucky circuit court on behalf of the estates of 11 people, alleging the company’s dry acid dialysis products were defective and caused patients injuries and death. Fresenius is the world’s largest provider of dialysis products and services. The company supplies dry acid concentrates GranuFlo and NaturaLyte to both Fresenius-owned and non-Fresenius-owned dialysis clinics. The products are used during dialysis to help maintain proper electrolyte levels. Both GranuFlo and NaturaLyte contain an ingredient that metabolizes in the body to bicarbonate. Too much bicarbonate in the blood can cause cardiovascular problems including sudden ... Read More

Lawsuit claims Fresenius dialysis product caused man’s death

A Mississippi woman is suing Fresenius Medical Care claiming the dialysis provider gave her husband a lethal dose of a dialysis product that caused him to suffer a fatal cardiovascular event. Marshall Russell Phillips was undergoing dialysis at a treatment center in Brandon, Miss., during which he was administered NaturaLyte and/or GranuFlo dialysis products. The dialysis concentrates are used to help balance electrolytes in patients undergoing dialysis. Fresenius, a world leader in dialysis products and services, manufactures NaturaLyte and GranuFlo and distributes it to both Fresenius-owned and non-Fresenius-owned dialysis clinics. In 2012, the company discovered that the dosing instructions on the ... Read More

Fresenius dialysis product recall shuts down only clinic in American Samoa

American Samoa’s only dialysis clinic was shut down for two days last week after workers were notified that one of its dialysis concentrates was recalled due to possible bacterial contamination. There were no other concentrates available, and dialysis patients were forced to wait until dialysis products provider Fresenius Medical Care could ship replacement concentrates to this small island about 2,300 miles south of Hawaii. Dialysis is a life saving process during which machines filter the blood of patients whose kidneys no longer function properly. Patients generally require about three to four dialysis treatments per week. Going more than three or ... Read More

Study reveals more dialysis patient deaths occur in winter months

Dialysis patients are more likely to die during winter months, according to a study presented at the European Renal Association-European Dialysis and Transplant Association’s 52nd congress held in London. The study was a retrospective cohort conducted by researchers with the Medical University of Graz, Austria, and involved nearly 2,500 dialysis patients. During the study, 1,836 patients died. Data revealed that all-cause mortality was highest in winter, with 1.60 deaths per 100 patient-months, and lowest in summer, with 1.06 deaths per patient months. The findings are similar to a U.S. study conducted by researchers with the Renal Research Institute in New ... Read More

GranuFlo, NaturaLyte bellwether trials scheduled for early 2016

More than 1,800 lawsuits claiming dialysis service and supplier Fresenius Medical Care failed to warn doctors or patients that its dialysis products GranuFlo and NaturaLyte could cause serious cardiovascular risks have been consolidated into a multidistrict litigation (MDL). The lawsuits were consolidated under U.S. District Judge Douglas P. Woodlock in the District of Massachusetts. The personal injury and wrongful death lawsuits claim that dialysis giant Fresenius knew the dangers of its dialysis concentrates but neglected to warn health care providers, and also failed to properly train them on how to use the solutions safely. Fresenius manufactures GranuFlo and NaturaLyte, solutions ... Read More